Lucentis data quantify vision gains as AMD market heats up
Genentech said its acute macular degeneration (AMD) treatment Lucentis maintained vision in study subjects and improved it in up to ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.